Stay updated on Acalabrutinib in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib in Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added related topics to the page: 'Ovarian cancer' and 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-18T07:12:46.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A minor site-wide revision marker (Revision: v3.4.2) was added, and a funding notice, a related topic (MedlinePlus Genetics), and an older revision reference (v3.4.1) were removed. These adjustments affect navigation and ancillary references but do not alter the study details for NCT02537444.
    Difference
    0.7%
    Check dated 2026-02-11T05:41:01.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Notice at the top of the page now includes a government funding lapse advisory and a version update (Revision: v3.4.1) replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T05:31:23.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows a glossary and related topics (Ovarian cancer, MedlinePlus Genetics) and updated footer/version information (Revision: v3.4.0) with minor removals of old QC data; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-01-28T04:00:14.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision notice updated to v3.3.4 and related topics such as Ovarian cancer and MedlinePlus Genetics have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-14T01:29:31.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A Locations section has been added with Arizona and Pennsylvania study sites (replacing the prior standalone Arizona Locations and Pennsylvania Locations blocks). The page revision is updated to v3.3.3, and the HHS Vulnerability Disclosure link has been removed.
    Difference
    0.4%
    Check dated 2025-12-23T10:16:49.000Z thumbnail image

Stay in the know with updates to Acalabrutinib in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.